{
    "2021-07-20": [
        [
            {
                "time": "",
                "original_text": "此外，，在政策、人才回流等多重因素推动下，我国创新药研发火热，这也进一步促进了我国CXO行业发展。",
                "features": {
                    "keywords": [
                        "政策",
                        "人才回流",
                        "创新药研发",
                        "CXO行业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "黄金赛道CXO|从实验室化学到CXO“全家桶”，康龙化成要向药明康德看齐？",
                "features": {
                    "keywords": [
                        "CXO",
                        "康龙化成",
                        "药明康德"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "CXO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周观点：中报业绩陆续披露 关注基本面变动",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报业绩",
                        "基本面变动"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【行情】CRO概念持续走弱，皓元医药跌超5%，睿智医药、康龙化成、昭衍新药跟跌",
                "features": {
                    "keywords": [
                        "CRO概念",
                        "皓元医药",
                        "睿智医药",
                        "康龙化成",
                        "昭衍新药"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "CRO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759)：H1收入持续提速 运营效率提升拉动业绩大幅增长",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "H1收入",
                        "运营效率",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药-马帅】康龙化成：一体化服务平台驱动各项业务快速发展，2021H1业绩增长符合预期",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "一体化服务平台",
                        "业务发展",
                        "2021H1业绩"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}